Lawrence E Garbo Selected Research

(N(1),N(12))bis(ethyl)- 6,7- dehydrospermine

1/2021

A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lawrence E Garbo Research Topics

Disease

1	Lymphoma (Lymphomas) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 11/2011
1	Disease Progression 11/2011
1	Neutropenia 10/2009
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2009

Drug/Important Bio-Agent (IBA)

2	Gemcitabine FDA Link 01/2021 - 10/2009
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	Sunitinib (Sutent)FDA Link 01/2021
1	(N(1),N(12))bis(ethyl)- 6,7- dehydrospermineIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	PolyaminesIBA 01/2021
1	SpermineIBA 01/2021
1	AndrogensIBA 11/2011
1	Azacitidine (5 Azacytidine)FDA Link 11/2011
1	DNA (Deoxyribonucleic Acid)IBA 11/2011
1	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2009
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2009
1	Rituximab (Mabthera)FDA Link 10/2009

Therapy/Procedure

1	Therapeutics 01/2021
1	Castration 11/2011